CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to compare the efficacy and safety of albuterol/budesonide to albuterol in changes in airway inflammation, asthma...
Phase 4
Pottstown, Pennsylvania, United States and 18 other locations
immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...
Phase 1
Philadelphia, Pennsylvania, United States and 9 other locations
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
Philadelphia, Pennsylvania, United States and 65 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Philadelphia, Pennsylvania, United States and 247 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Philadelphia, Pennsylvania, United States and 314 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Philadelphia, Pennsylvania, United States and 6 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Philadelphia, Pennsylvania, United States and 73 other locations
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...
Phase 4
Philadelphia, Pennsylvania, United States and 36 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
Pottstown, Pennsylvania, United States and 134 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Philadelphia, Pennsylvania, United States and 84 other locations
Clinical trials
Research sites
Resources
Legal